GE HealthCare inks Icometrix buyout to acquire brain MRI software
The deal includes AI-powered software for detecting known side effects of recently launched Alzheimer’s drugs.
Dive Brief:
- GE HealthCare has struck a deal to buy brain analysis business Icometrix for an undisclosed sum, the companies said Wednesday.
- Icometrix received 510(k) clearance for its brain imaging software in 2016. The company went on to receive clearances for modules with specific uses, including technology for detecting known side effects of recently launched Alzheimer’s disease drugs.
- GE HealthCare focused on the Alzheimer’s module in its statement about the deal. The company plans to expand access to the module on all vendor MRI systems via commercial distribution and clinical integration.
